TTP as a surrogate endpoint in advanced hepatocellular carcinoma treated with molecular targeted therapy: meta-analysis of randomised controlled trials
Dae-Won Lee,Myoung‐jin Jang,Kyung-Hun Lee,Eun Ju Cho,Jeong‐Hoon Lee,Su Jong Yu,Yoon Jun Kim,Jung‐Hwan Yoon,Tae‐Yong Kim,Sae‐Won Han,Do‐Youn Oh,Seock‐Ah Im,Tae-You Kim
Our study results suggest that TTP could be used as a surrogate marker for OS in the clinical trials of advanced HCC. However, the results suggest modest correlation between treatment effects on TTP and OS.
PDF的下载单位、IP信息已删除
(2025-6-4)
BowieHuang
Twonej
无极微光
Criminology34
HOAN
专注的问寒
风清扬
pluto
核桃
小青椒
滕祥
Ky_Mac
尉迟希望
wanci
spc68
蜀安
zhonglv7
tuanheqi
Singularity
ppg123
小李
sswbzh
猪猪hero
Mic
皖公网安备34019202002308
